{"nct_id":"NCT04387461","title":"Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin","status":"COMPLETED","status_verified_date":"2024-09","start_date":"2020-12-08","start_date_type":"ACTUAL","primary_completion_date":"2023-03-07","primary_completion_date_type":"ACTUAL","completion_date":"2024-05-28","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CGON"]}